QX006N is a humanized monoclonal antibody inhibitor targeting the human interferon alpha/beta receptor 1 (IFNAR1). It is promising for research in systemic lupus erythematosus (SLE) and other IFNAR1-related autoimmune diseases.
Target:
IFNAR
* VAT and and shipping costs not included. Errors and price changes excepted
